| Followers | 10 |
| Posts | 605 |
| Boards Moderated | 0 |
| Alias Born | 06/30/2014 |
Friday, July 17, 2020 12:33:01 PM
Expected RLMD to drop to 36-37 (it hit 38.5) but bounced to 43.
A close above 45.5 would repair the chart trend.
https://stockcharts.com/h-sc/ui?s=RLMD
The chart seems to show it could drop again but I’m not selling,
Oppenheimer just issued a buy w price target of $75. All 5 reports indicate the revenues from their drug will be 1b + within a few years. Fibonacci indicates 71 after closing above 50.
I’ve predicted it will hit $500 soon after REL-1017 is approved and sales begin. It’s the safest, cheapest and fastest acting drug for depression yet developed. Missed my July 4th target. BTD would help.
I’m riding this like Ahab rode Moby Dick but hoping for a better ending.
A close above 45.5 would repair the chart trend.
https://stockcharts.com/h-sc/ui?s=RLMD
The chart seems to show it could drop again but I’m not selling,
Oppenheimer just issued a buy w price target of $75. All 5 reports indicate the revenues from their drug will be 1b + within a few years. Fibonacci indicates 71 after closing above 50.
I’ve predicted it will hit $500 soon after REL-1017 is approved and sales begin. It’s the safest, cheapest and fastest acting drug for depression yet developed. Missed my July 4th target. BTD would help.
I’m riding this like Ahab rode Moby Dick but hoping for a better ending.
Recent RLMD News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2026 08:59:47 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 05/13/2026 08:53:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2026 08:05:56 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/04/2026 08:25:12 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/17/2026 08:31:38 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/17/2026 08:30:44 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/10/2026 04:15:17 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/09/2026 08:20:40 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/06/2026 08:35:14 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 04/03/2026 08:30:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/20/2026 08:52:59 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/19/2026 08:25:32 PM
- Relmada Therapeutics shares jump 25% after promising bladder cancer trial results • IH Market News • 03/09/2026 01:51:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 11:11:01 AM
- Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders • PR Newswire (Canada) • 02/26/2026 05:07:00 PM
- Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders • PR Newswire (US) • 02/26/2026 05:07:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/17/2026 02:15:23 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/30/2026 10:14:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/16/2025 02:30:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/16/2025 02:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/16/2025 02:29:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/16/2025 02:28:48 PM
